OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Olon began construction of a GMP facility for biologic APIs in Capua, Italy.
Olon SpA, an API contract development and manufacturing organization (CDMO) and generics supplier, began construction on a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy, according to a July 24, 2019 press release.
"I am pleased to announce the start of this GMP capacity expansion just within six months after the acquisition of Capua BioServices. This truly confirms the real opportunity to accelerate growth in Olon's CDMO service positioning and to be recognized as European Leader in the CDMO of microbial fermentation," said Paolo Tubertini, CEO of Olon, in the press release.
The construction of this new GMP facility is associated with a long-term strategic partnership with a large pharmaceutical company. The engineering project is designed to support the manufacture of multiple products, up to commercial scale.
Olon is headquartered in Milan, Italy and has 11 manufacturing facilities in Europe (Italy and Spain), the US (Concord, OH), and India (Mahad).